Prediction of responders to NAC in MIBC- Fantastic talk by Peter Black at #CUA2018

Congratulations all, including Lucia Nappi and Daniel Khalaf !

Delighted to have contributed a section on continence in adults with frailty to this eLearning programme The programme aims to standardise training and knowledge of frailty as a complex multi-system, long term condition 👉 e-lfh.org.uk/programmes/fra… #NHSfrailtyfocus #resetfrailty

Super-Saturdays in the news today University Hospital Southampton 💙 Wessex Neurological Centre The model started with Julian Smith urology with our partners Hampshire Hospitals Now being used across specialties Thanks again to all our amazing staff for giving up their time #clearthebacklog bbc.co.uk/iplayer/episod…

Thanks CIHR-ICRH | L'ISCR des IRSC for funding our pilot study in germ cell tumors! We are committed to move toward a biological based care model in testicular cancer. Craig Nichols BC Cancer Vancouver Prostate Centre

Good opportunity to join my lab and the incredible scientists team at the Vancouver Prostate Centre and to live in the beautiful British Columbia!

It is almost 5 years to the day that we performed the first Rezum cases in the UK. Thanks to all involved for their hard work. We are delighted to share our experience with this recent publication. Hampshire Hospitals University of Winchester European Association of Urology (EAU) Boston Scientific Urology Urology Partners #bph #patientchoice

Whilst PROMS score summaries are important, and shown in the PROTECT NEJM QoL paper, these data present the very significant side effects from radical therapy in a manner that is more easily understood by patients (and me).

Here’s our nature paper on v deep whole-genome sequencing of serial ctDNA and met tissue. Cameron Herberts, Matti, Joonatan et al applied new methods to give fascinating insight into temporal #ProstateCancer clonal complexity and evolution of resistance. 1/7 nature.com/articles/s4158…

What is happening to men after a negative targeted biopsy for PIRADS 4/5? We followed-up on 222 negative men out of a cohort of 1546.Paper is available Scientific Reports or rdcu.be/cTonh great work by Miriam Reuter& Kira Furlano Martin Schostak, MD PhD Geoffrey A. Sonn, MD Veeru Kasi

The Phil Taylor of fusion biopsies talks about his Koelis biopsy experience at the Imperial Masterclass. 🎯 Imperial Prostate Hashim U. Ahmed KoelisUK Urology Partners

Looking forward to the Koelis Masterclass tomorrow. Plenty of debate we hope. Genuine precision for a point? Simon Bott Paul POMMEL KoelisUK Kebomed UK Werner Struss @radhraj41 Amr Emara Mohamed Noureldin 🇪🇬🇬🇧 #180

Great presentation by Simon Bott about the development of Prostate biopsy. From cognitive saturation to cutting edge fusion targeted. KOELIS Kebomed UK Richard Hindley Urology Partners Ocean Med® Mohamed Noureldin 🇪🇬🇬🇧 Werner Struss

For those who do not know Rudolf Hohenfellner, please take a read of this short profile - a real icon in German Urology! Dr. Sebastian Melchior Markus Hohenfellner

#AUA23 Alexander Light presents outcomes from the FORECAST trial Systematic & MRI-targeted biopsy strategies for the detection of radiorecurrent PCa ➡️ MRI-targeted bx alone detects majority of recurrences @ patient level ➡️ Additional systematic bx needed to accurately map prostate

The 3rd KOELIS  Fusion LATP Masterclass. Taking place at Hampshire Hospitals on the 13th of Oct. A great opportunity to discover more about MRI/US Fusion LATP, pathway delivery, MRI annotation, business case management and surgical technique. DM for more details Kebomed UK

Thank you to all the faculty, delegates and industry partners who came together to make the Autumn KOELIS UK Masterclass such a sucess. A brilliant day and we're already looking forward to the Spring course. Richard Hindley Simon Bott Yehia Zaky Werner Struss Chloé Gubby

Great to be able to perform my first iTind procedure today at The Hampshire Clinic. A welcome addition to the BPH treatment portfolio, particularly for younger men. Hoping we will also soon be up and running in the PREMISE trial. Olympus Circle Health Urology Partners